| Anna B Wherry, PT | |
|
524 E Park St, Butte, MT 59701-1929 | |
| (406) 782-4748 | |
| (406) 782-4375 |
| Full Name | Anna B Wherry |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 27 Years |
| Location | 524 E Park St, Butte, Montana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083696942 | NPI | - | NPPES |
| MSF1158540 | Other | MT | WORKERS COMP |
| 0340986 | Medicaid | MT | |
| 000060298 | Other | MT | BC/BS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 1298PT (Montana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Butte Physical Therapy Center Inc | 9234101486 | 3 |
News Archive
Vivaglobin (subcutaneous immunoglobulin [IgG]) (SCIg) is an effective and safe initial therapy for treatment-naive patients with primary immunodeficiency (PI) and may offer an attractive alternative to intravenous IgG (IVIg) therapy in the newly diagnosed, according to data presented today at the XIVth Meeting of the European Society for Immunodeficiencies.
SpineAlign Medical Inc. announced today that it has chosen a new trademark name, VerteLift, for its vertebral implant system. Formerly called the SpineAlign System, the name reflects the advantages of the product that the Company will leverage going forward.
There is safety in numbers. That's one of the key findings of a study published today in CMAJ Open that found a child's risk of death or injury in a residential fire was greatly reduced in neighbourhoods with larger than average households.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that its applications for ALN-TTR01 have been given clearance by Portuguese, Swedish, and British regulatory authorities to begin clinical testing. The trial will begin enrolling patients shortly in a blinded, randomized, placebo-controlled, multicenter Phase I study.
The Kenyatta National Hospital Ethics and Research Board recently approved the first human clinical trial in Kenya of an herbal product to treat HIV/AIDS, Kenya's Nation reports.
› Verified 2 days ago
| Provider Name | Butte Physical Therapy Center Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1821118423 PECOS PAC ID: 9234101486 Enrollment ID: O20040809001290 |
News Archive
Vivaglobin (subcutaneous immunoglobulin [IgG]) (SCIg) is an effective and safe initial therapy for treatment-naive patients with primary immunodeficiency (PI) and may offer an attractive alternative to intravenous IgG (IVIg) therapy in the newly diagnosed, according to data presented today at the XIVth Meeting of the European Society for Immunodeficiencies.
SpineAlign Medical Inc. announced today that it has chosen a new trademark name, VerteLift, for its vertebral implant system. Formerly called the SpineAlign System, the name reflects the advantages of the product that the Company will leverage going forward.
There is safety in numbers. That's one of the key findings of a study published today in CMAJ Open that found a child's risk of death or injury in a residential fire was greatly reduced in neighbourhoods with larger than average households.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that its applications for ALN-TTR01 have been given clearance by Portuguese, Swedish, and British regulatory authorities to begin clinical testing. The trial will begin enrolling patients shortly in a blinded, randomized, placebo-controlled, multicenter Phase I study.
The Kenyatta National Hospital Ethics and Research Board recently approved the first human clinical trial in Kenya of an herbal product to treat HIV/AIDS, Kenya's Nation reports.
› Verified 2 days ago
| Provider Name | Stenson Physical Therapy |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1558514950 PECOS PAC ID: 6800957390 Enrollment ID: O20081202000599 |
News Archive
Vivaglobin (subcutaneous immunoglobulin [IgG]) (SCIg) is an effective and safe initial therapy for treatment-naive patients with primary immunodeficiency (PI) and may offer an attractive alternative to intravenous IgG (IVIg) therapy in the newly diagnosed, according to data presented today at the XIVth Meeting of the European Society for Immunodeficiencies.
SpineAlign Medical Inc. announced today that it has chosen a new trademark name, VerteLift, for its vertebral implant system. Formerly called the SpineAlign System, the name reflects the advantages of the product that the Company will leverage going forward.
There is safety in numbers. That's one of the key findings of a study published today in CMAJ Open that found a child's risk of death or injury in a residential fire was greatly reduced in neighbourhoods with larger than average households.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that its applications for ALN-TTR01 have been given clearance by Portuguese, Swedish, and British regulatory authorities to begin clinical testing. The trial will begin enrolling patients shortly in a blinded, randomized, placebo-controlled, multicenter Phase I study.
The Kenyatta National Hospital Ethics and Research Board recently approved the first human clinical trial in Kenya of an herbal product to treat HIV/AIDS, Kenya's Nation reports.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anna B Wherry, PT 915 14th St, Butte, MT 59701-8318 Ph: (406) 782-7839 | Anna B Wherry, PT 524 E Park St, Butte, MT 59701-1929 Ph: (406) 782-4748 |
News Archive
Vivaglobin (subcutaneous immunoglobulin [IgG]) (SCIg) is an effective and safe initial therapy for treatment-naive patients with primary immunodeficiency (PI) and may offer an attractive alternative to intravenous IgG (IVIg) therapy in the newly diagnosed, according to data presented today at the XIVth Meeting of the European Society for Immunodeficiencies.
SpineAlign Medical Inc. announced today that it has chosen a new trademark name, VerteLift, for its vertebral implant system. Formerly called the SpineAlign System, the name reflects the advantages of the product that the Company will leverage going forward.
There is safety in numbers. That's one of the key findings of a study published today in CMAJ Open that found a child's risk of death or injury in a residential fire was greatly reduced in neighbourhoods with larger than average households.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that its applications for ALN-TTR01 have been given clearance by Portuguese, Swedish, and British regulatory authorities to begin clinical testing. The trial will begin enrolling patients shortly in a blinded, randomized, placebo-controlled, multicenter Phase I study.
The Kenyatta National Hospital Ethics and Research Board recently approved the first human clinical trial in Kenya of an herbal product to treat HIV/AIDS, Kenya's Nation reports.
› Verified 2 days ago
Southwest Montana Veterans Home Physical Therapist Medicare: Medicare Enrolled Practice Location: 65 Veterans Circle, Butte, MT 59701 Phone: 406-792-3100 | |
Desiree Van Blaricom, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 435 S Crystal St, Ste 400, Butte, MT 59701 Phone: 406-496-3456 Fax: 406-496-3457 | |
Copper Ridge Nursing And Rehab Center Llc Physical Therapist Medicare: Medicare Enrolled Practice Location: 3251 Nettie St, Butte, MT 59701 Phone: 801-601-1450 | |
Mrs. Ajkena Coate, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 3251 Nettie St, Butte, MT 59701 Phone: 406-939-4353 | |
Melissa Joy Swanson, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 120 Foxtail Lane, Butte, MT 59701 Phone: 406-490-3634 | |
Holly Ferguson I, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 400 S Clark St, Butte, MT 59701 Phone: 406-723-2522 Fax: 406-723-2544 |